The mechanisms that underlie glucose sensing during hypoglycaemia in diabetes

Diabetic Medicine

Volumn 25, Issue 5, 2008, Pages 513-522

  McCrimmon, R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AMP activated protein kinase; Glucose excited neurons; Glucose inhibited neurons; Hypoglycaemia; Ventromedial hypothalamus

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); GLUCOKINASE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

DIABETES MELLITUS; ENZYME ANALYSIS; GLUCOSE METABOLISM; HUMAN; HYPOGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL; NONHUMAN; PANCREAS ISLET BETA CELL; REVIEW;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIA; HYPOTHALAMUS, MIDDLE; INSULIN; RECEPTORS, SENSORY;

EID: 42549161859     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02376.x     Document Type: Review

References (110)

1. Cryer PE. Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDM. Diabetes 1994 43 : 1378 1389.
2. Frier BM, Fisher BM. Hypoglycaemia and Diabetes: Clinical and Physiological Aspects. London : Edward Arnold, 1993.
3. Thorens B, Larsen PJ. Gut-derived signaling molecules and vagal afferents in the control of glucose and energy homeostasis. Curr Opin Clin Nutr Metab Care 2004 7 : 471 478.
4. Burcelin R, Crivelli V, Perrin C, Da Costa A, Mu J, Kahn BB et al. GLUT4, AMP kinase, but not the insulin receptor, are required for hepatoportal glucose sensor-stimulated muscle glucose utilization. J Clin Invest 2003 111 : 1555 1562.
5. Burcelin R, Da Costa A, Drucker D, Thorens B. Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor. Diabetes 2001 50 : 1720 1728.
6. Burcelin R, Dolci W, Thorens B. Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice. Diabetes 2000 49 : 1643 1648.
7. Donovan CM. Portal vein glucose sensing. Diabetes Nutr Metab 2002 15 : 308 312.
8. Donovan CM, Hamilton-Wessler M, Halter JB, Bergman RN. Primacy of liver glucosensors in the sympathetic response to progressive hypoglycemia. Proc Natl Acad Sci USA 1994 91 : 2863 2867.
9. Hevener AL, Bergman RN, Donovan CM. Novel glucosensor for hypoglycemic detection localized to the portal vein. Diabetes 1997 46 : 1521 1525.
10. Pardal R, Lopez-Barneo J. Low glucose-sensing cells in the carotid body. Nat Neurosci 2002 5 : 197 198.
11. Shoji S. Glucose regulation of synaptic transmission in the dorsolateral septal nucleus of the rat. Synapse 1992 12 : 322 332.
12. Nakano Y, Oomura Y, Lenard L, Nishino H, Aou S, Yamamoto T et al. Feeding-related activity of glucose-and morphine-sensitive neurons in the monkey amygdala. Brain Res 1986 399 : 167 172.
13. Lee K, Dixon AK, Freeman TC, Richardson PJ. Identification of an ATP-sensitive potassium channel current in rat striatal cholinergic interneurones. J Physiol 1998 510 : 441 453.
14. Lee K, Dixon AK, Rowe IC, Ashford ML, Richardson PJ. The high-affinity sulphonylurea receptor regulates KATP channels in nerve terminals of the rat motor cortex. J Neurochem 1996 66 : 2562 2571.
15. Adachi A, Kobashi M, Miyoshi N, Tsukamoto G. Chemosensitive neurons in the area postrema of the rat and their possible functions. Brain Res Bull 1991 26 : 137 140.
16. Amoroso S, Schmid-Antomarchi H, Fosset M, Lazdunski M. Glucose, sulfonylureas, and neurotransmitter release: role of ATP-sensitive K+ channels. Science 1990 247 : 852 854.
17. During MJ, Leone P, Davis KE, Kerr D, Sherwin RS. Glucose modulates rat substantia nigra GABA release in vivo via ATP-sensitive potassium channels. J Clin Invest 1995 95 : 2403 2408.
18. Finta EP, Harms L, Sevcik J, Fischer HD, Illes P. Effects of potassium channel openers and their antagonists on rat locus coeruleus neurones. Br J Pharmacol 1993 109 : 308 315.
19. Karschin A, Brockhaus J, Ballanyi K. KATP channel formation by the sulphonylurea receptors SUR1 with Kir6.2 subunits in rat dorsal vagal neurons in situ. J Physiol 1998 509 : 339 346.
20. Funahashi H, Yada T, Muroya S, Takigawa M, Ryushi T, Horie S et al. The effect of leptin on feeding-regulating neurons in the rat hypothalamus. Neurosci Lett 1999 264 : 117 120.
21. Nagai K, Niijima A, Nagai N, Hibino H, Chun SJ, Shimizu K et al. Bilateral lesions of the hypothalamic suprachiasmatic nucleus eliminated sympathetic response to intracranial injection of 2-deoxy-D-glucose and VIP rescued this response. Brain Res Bull 1996 39 : 293 297.
22. Oomura Y, Ono T, Ooyama H, Wayner MJ. Glucose and osmosensitive neurones of the rat hypothalamus. Nature 1969 222 : 282 284.
23. Orsini JC, Himmi T, Wiser AK, Perrin J. Local versus indirect action of glucose on the lateral hypothalamic neurons sensitive to glycemic level. Brain Res Bull 1990 25 : 49 53.
24. Orsini JC, Wiser AK, Himmi T, Boyer A, Perrin J. Sensitivity of lateral hypothalamic neurons to glycemic level: possible involvement of an indirect adrenergic mechanism. Brain Res Bull 1991 26 : 473 478.
25. Silver IA, Ereciska M. Glucose-induced intracellular ion changes in sugar-sensitive hypothalamic neurons. J Neurophysiol 1998 79 : 1733 1745.
26. Ritter S, Dinh TT, Zhang Y. Localization of hindbrain glucoreceptive sites controlling food intake and blood glucose. Brain Res 2000 856 : 37 47.
27. Ashford ML, Boden PR, Treherne JM. Tolbutamide excites rat glucoreceptive ventromedial hypothalamic neurones by indirect inhibition of ATP-K+ channels. Br J Pharmacol 1990 101 : 531 540.
28. Borg MA, Sherwin RS, Borg WP, Tamborlane WV, Shulman GI. Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest 1997 99 : 361 365.
29. Borg WP, During MJ, Sherwin RS, Borg MA, Brines ML, Shulman GI. Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest 1994 93 : 1677 1682.
30. Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI. Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes 1995 44 : 180 184.
31. Evans SB, Wilkinson CW, Gronbeck P, Bennett JL, Taborsky GJ Jr., Figlewicz DP. Inactivation of the PVN during hypoglycemia partially simulates hypoglycemia-associated autonomic failure. Am J Physiol-Regul Integr Comp Physiol 2003 284 : R57 65.
32. Evans SB, Wilkinson CW, Gronbeck P, Bennett JL, Zavosh A, Taborsky GJ Jr. et al. Inactivation of the DMH selectively inhibits the ACTH and corticosterone responses to hypoglycemia. Am J Physiol-Regul Integr Comp Physiol 2004 286 : R123 128.
33. de Vries MG, Arseneau LM, Lawson ME, Beverly JL. Extracellular glucose in rat ventromedial hypothalamus during acute and recurrent hypoglycemia. Diabetes 2003 52 : 2767 2773.
34. McNay EC, Gold PE. Extracellular glucose concentrations in the rat hippocampus measured by zero-net-flux: effects of microdialysis flow rate, strain, and age. J Neurochem 1999 72 : 785 790.
35. Silver IA, Erecinska M. Extracellular glucose concentration in mammalian brain: continuous monitoring of changes during increased neuronal activity and upon limitation in oxygen supply in normo-, hypo-, and hyperglycemic animals. J Neurosci 1994 14 : 5068 5076.
36. Mayer J. Glucostatic mechanism of regulation of food intake. New Engl J Med 1953 249 : 13 16.
37. Magistretti PJ, Sorg O, Naichen Y, Pellerin L, de Rham S, Martin JL. Regulation of astrocyte energy metabolism by neurotransmitters. Renal Physiol Biochem 1994 17 : 168 171.
38. Magistretti PJ, Sorg O, Yu N, Martin JL, Pellerin L. Neurotransmitters regulate energy metabolism in astrocytes: implications for the metabolic trafficking between neural cells. Dev Neurosci 1993 15 : 306 312.
39. Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci USA 1994 91 : 10625 10629.
40. Song Z, Routh VH. Differential effects of glucose and lactate on glucosensing neurons in the ventromedial hypothalamic nucleus. Diabetes 2005 54 : 15 22.
41. Borg MA, Tamborlane WV, Shulman GI, Sherwin RS. Local lactate perfusion of the ventromedial hypothalamus suppresses hypoglycemic counterregulation. Diabetes 2003 52 : 663 666.
42. King P, Kong MF, Parkin H, MacDonald IA, Barber C, Tattersall RB. Intravenous lactate prevents cerebral dysfunction during hypoglycaemia in insulin-dependent diabetes mellitus. Clin Sci 1998 94 : 157 163.
43. Maran A, Cranston I, Lomas J, Macdonald I, Amiel SA. Protection by lactate of cerebral function during hypoglycaemia. Lancet 1994 343 : 16 20.
44. Thurston JH, Hauhart RE. Effect of momentary stress on brain energy metabolism in weanling mice: apparent use of lactate as cerebral metabolic fuel concomitant with a decrease in brain glucose utilization. Metab Brain Dis 1989 4 : 177 186.
45. Thurston JH, Hauhart RE, Schiro JA. Lactate reverses insulin-induced hypoglycemic stupor in suckling-weanling mice: biochemical correlates in blood, liver, and brain. J Cereb Blood Flow Metab 1983 3 : 498 506.
46. Kennedy HJ, Pouli AE, Ainscow EK, Jouaville LS, Rizzuto R, Rutter GA. Glucose generates sub-plasma membrane ATP microdomains in single islet beta-cells. Potential role for strategically located mitochondria. J Biol Chem 1999 274 : 13281 13291.
47. Routh VH. Glucose-sensing neurons: are they physiologically relevant? Physiol Behav 2002 76 : 403 413.
48. Schuit FC, Huypens P, Heimberg H, Pipeleers DG. Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes 2001 50 : 1 11.
49. Matschinsky FM. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 1996 45 : 223 241.
50. Levin BE, Routh VH, Kang L, Sanders NM, Dunn-Meynell AA. Neuronal glucosensing: what do we know after 50 years? Diabetes 2004 53 : 2521 2528.
51. Ashford ML, Boden PR, Treherne JM. Glucose-induced excitation of hypothalamic neurones is mediated by ATP-sensitive K+ channels. Pflugers Archiv-Eur J Physiol 1990 415 : 479 483.
52. Dunn-Meynell AA, Rawson NE, Levin BE. Distribution and phenotype of neurons containing the ATP-sensitive K+ channel in rat brain. Brain Res 1998 814 : 41 54.
53. Dunn-Meynell AA, Routh VH, McArdle JJ, Levin BE. Low-affinity sulfonylurea binding sites reside on neuronal cell bodies in the brain. Brain Res 1997 745 : 1 9.
54. Kang L, Routh VH, Kuzhikandathil EV, Gaspers LD, Levin BE. Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurons. Diabetes 2004 53 : 549 559.
55. Dallaporta M, Perrin J, Orsini JC. Involvement of adenosine triphosphate-sensitive K+ channels in glucose-sensing in the rat solitary tract nucleus. Neurosci Lett 2000 278 : 77 80.
56. Spanswick D, Smith MA, Groppi VE, Logan SD, Ashford ML. Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature 1997 390 : 521 525.
57. Yang XJ, Kow LM, Funabashi T, Mobbs CV. Hypothalamic glucose sensor. Similarities to and differences from pancreatic beta-cell mechanisms. Diabetes 1999 48 : 1763 1772.
58. Miki T, Liss B, Minami K, Shiuchi T, Saraya A, Kashima Y et al. ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis. Nat Neurosci 2001 4 : 507 512.
59. Evans ML, McCrimmon RJ, Flanagan DE, Keshavarz T, Fan X, McNay EC et al. Hypothalamic ATP-sensitive K+ channels play a key role in sensing hypoglycemia and triggering counterregulatory epinephrine and glucagon responses. Diabetes 2004 53 : 2542 2551.
60. McCrimmon RJ, Evans ML, Fan X, McNay EC, Chan O, Ding Y et al. Activation of KATP channels in the ventromedial hypothalamus amplifies counterregulatory hormone responses to hypoglycemia in normal and recurrently hypoglycemic rats. Diabetes 2005 54 : 3169 3174.
61. Dunn-Meynell AA, Routh VH, Kang L, Gaspers L, Levin BE. Glucokinase is the likely mediator of glucosensing in both glucose-excited and glucose-inhibited central neurons. Diabetes 2002 51 : 2056 2065.
62. Jetton TL, Liang Y, Pettepher CC, Zimmerman EC, Cox FG, Horvath K et al. Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut. J Biol Chem 1994 269 : 3641 3654.
63. Lynch RM, Tompkins LS, Brooks HL, Dunn-Meynell AA, Levin BE. Localization of glucokinase gene expression in the rat brain. Diabetes 2000 49 : 693 700.
64. Wang R, Liu X, Hentges ST, Dunn-Meynell AA, Levin BE, Wang W et al. The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes 2004 53 : 1959 1965.
65. Kang L, Dunn-Meynell AA, Routh VH, Gaspers LD, Nagata Y, Nishimura T et al. Glucokinase is a critical regulator of ventromedial hypothalamic neuronal glucosensing. Diabetes 2006 55 : 412 420.
66. McNay EC, Gold PE. Age-related differences in hippocampal extracellular fluid glucose concentration during behavioral testing and following systemic glucose administration. J Gerontol Series A-Biol Sci Med Sci 2001 56 : B66 71.
67. Abi-Saab WM, Maggs DG, Jones T, Jacob R, Srihari V, Thompson J et al. Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. J Cereb Blood Flow Metab 2002 22 : 271 279.
68. Leloup C, Arluison M, Lepetit N, Cartier N, Marfaing-Jallat P, Ferre P et al. Glucose transporter 2 (GLUT 2): expression in specific brain nuclei. Brain Res 1994 638 : 221 226.
69. Marty N, Dallaporta M, Foretz M, Emery M, Tarussio D, Bady I et al. Regulation of glucagon secretion by glucose transporter Type 2 (glut2) and astrocyte-dependent glucose sensors. J Clin Invest 2005 115 : 3545 3553.
70. Song Z, Levin BE, McArdle JJ, Bakhos N, Routh VH. Convergence of pre- and postsynaptic influences on glucosensing neurons in the ventromedial hypothalamic nucleus. Diabetes 2001 50 : 2673 2681.
71. Canabal DD, Song Z, Potian JG, Beuve A, McArdle JJ, Routh VH. Glucose, insulin, and leptin signaling pathways modulate nitric oxide synthesis in glucose-inhibited neurons in the ventromedial hypothalamus. Am J Physiol-Regul Integr Comp Physiol 2007 292 : R1418 1428.
72. Hardie DG, Carling D. The AMP-activated protein kinase. Fuel gauge of the mammalian cell? Eur J Biochem 1997 246 : 259 273.
73. Turnley AM, Stapleton D, Mann RJ, Witters LA, Kemp BE, Bartlett PF. Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J Neurochem 1999 72 : 1707 1716.
74. Mountjoy PD, Bailey SJ, Rutter GA. Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activity. Diabetologia 2007 50 : 168 177.
75. Fioramonti X, Contie S, Song Z, Routh VH, Lorsignol A, Penicaud L. Characterization of glucose-sensing neuron subpopulations in the arcuate nucleus. Diabetes 2007 56 : 1219 1227.
76. McCrimmon RJ, Fan X, Ding Y, Zhu W, Jacob RJ, Sherwin RS. Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus. Diabetes 2004 53 : 1953 1958.
77. McCrimmon RJ, Fan X, Cheng H, McNay E, Chan O, Shaw M et al. Activation of AMP-activated protein kinase within the ventromedial hypothalamus amplifies counterregulatory hormone responses in rats with defective counterregulation. Diabetes 2006 55 : 1755 1760.
78. McCrimmon RJ, Shaw M, Fan X, Cheng H, Ding Y, Wang A et al. AMP-activated protein kinase (AMPK): a key mediator of hypoglycemia-sensing in the ventromedial hypothalamus (VMH). Diabetes 2006 55 (Suppl. 1 A15.
79. Claret M, Smith MA, Batterham RL, Selman C, Choudhury AI, Fryer LGD et al. AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. J Clin Invest 2007 117 : 2325 2336.
80. Chan O, Zhu W, Ding Y, McCrimmon RJ, Sherwin RS. Blockade of GABA(A) receptors in the ventromedial hypothalamus further stimulates glucagon and sympathoadrenal but not the hypothalamo-pituitary-adrenal response to hypoglycemia. Diabetes 2006 55 : 1080 1087.
81. Mokan M, Mitrakou A, Veneman T, Ryan C, Korytkowski M, Cryer P et al. Hypoglycemia unawareness in IDDM. Diabetes Care 1994 17 : 1397 1403.
82. White NH, Skor DA, Cryer PE, Levandoski LA, Bier DM, Santiago JV. Identification of Type 1 diabetic patients at increased risk for hypoglycemia during intensive insulin therapy. New Engl J Med 1983 308 : 485 491.
83. Fukuda M, Tanaka A, Tahara Y, Ikegami H, Yamamoto Y, Kumahara Y et al. Correlation between minimal secretory capacity of pancreatic beta-cells and stability of diabetic control. Diabetes 1988 37 : 81 88.
84. Asplin CM, Paquette TL, Palmer JP. In vivo inhibition of glucagon secretion by paracrine beta cell activity in man. J Clin Invest 1981 68 : 314 318.
85. Maruyama H, Hisatomi A, Orci L, Grodsky GM, Unger RH. Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest 1984 74 : 2296 2299.
86. Samols E, Stagner JI, Ewart RB, Marks V. The order of islet microvascular cellular perfusion is B - - A - - D in the perfused rat pancreas. J Clin Invest 1988 82 : 350 353.
87. Zhou H, Tran PO, Yang S, Zhang T, LeRoy E, Oseid E et al. Regulation of alpha-cell function by the beta-cell during hypoglycemia in Wistar rats: the 'switch-off' hypothesis. Diabetes 2004 53 : 1482 1487.
88. Zhou H, Zhang T, Oseid E, Harmon J, Tonooka N, Robertson RP. Reversal of defective glucagon responses to hypoglycemia in insulin-dependent autoimmune diabetic BB rats. Endocrinology 2007 148 : 2863 2869.
89. McCrimmon RJ, Evans ML, Jacob RJ, Fan X, Zhu Y, Shulman GI et al. AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat. Am J Physiol-Endocrinol Metab 2002 283 : E1076 1083.
90. Taborsky GJ Jr., Ahren B, Havel PJ. Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired alpha-cell responses in Type 1 diabetes. Diabetes 1998 47 : 995 1005.
91. Group TDR. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. American Journal of Medicine 1991 90 : 450 459.
92. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 1988 37 : 901 907.
93. Davis MR, Shamoon H. Counterregulatory adaptation to recurrent hypoglycemia in normal humans. J Clin Endocrinol Metab 1991 73 : 995 1001.
94. Davis SN, Galassetti P, Wasserman DH, Tate D. Effects of antecedent hypoglycemia on subsequent counterregulatory responses to exercise. Diabetes 2000 49 : 73 81.
95. Heller SR, Cryer PE. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 1991 40 : 223 226.
96. Flanagan DE, Keshavarz T, Evans ML, Flanagan S, Fan X, Jacob RJ et al. Role of corticotrophin-releasing hormone in the impairment of counterregulatory responses to hypoglycemia. Diabetes 2003 52 : 605 613.
97. Powell AM, Sherwin RS, Shulman GI. Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits. J Clin Invest 1993 92 : 2667 2674.
98. Borg MA, Borg WP, Tamborlane WV, Brines ML, Shulman GI, Sherwin RS. Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats. Diabetes 1999 48 : 584 587.
99. Song Z, Routh VH. Recurrent hypoglycemia reduces the glucose sensitivity of glucose-inhibited neurons in the ventromedial hypothalamus nucleus. Am J Physiol-Regul Integr Comp Physiol 2006 291 : R1283 1287.
100. Kumagai AK, Kang YS, Boado RJ, Pardridge WM. Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia. Diabetes 1995 44 : 1399 1404.
101. Vannucci RC, Nardis EE, Vannucci SJ, Campbell PA. Cerebral carbohydrate and energy metabolism during hypoglycemia in newborn dogs. Am J Physiol 1981 240 : R192 199.
102. Boyle PJ, Kempers SF, O'Connor AM, Nagy RJ. Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. New Engl J Med 1995 333 : 1726 1731.
103. Mason GF, Petersen KF, Lebon V, Rothman DL, Shulman GI. Increased brain monocarboxylic acid transport and utilization in Type 1 diabetes. Diabetes 2006 55 : 929 934.
104. Segel SA, Fanelli CG, Dence CS, Markham J, Videen TO, Paramore DS et al. Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia. Diabetes 2001 50 : 1911 1917.
105. Choi IY, Seaquist ER, Gruetter R. Effect of hypoglycemia on brain glycogen metabolism in vivo. J Neurosci Res 2003 72 : 25 32.
106. Gruetter R. Glycogen: the forgotten cerebral energy store. J Neurosci Res 2003 74 : 179 183.
107. McCrimmon RJ, Song Z, Cheng H, McNay EC, Weikart-Yeckel C, Fan X et al. Corticotrophin-releasing factor receptors within the ventromedial hypothalamus regulate hypoglycemia-induced hormonal counterregulation. J Clin Invest 2006 116 : 1723 1730.
108. Cheng H, Zhou L, Zhu W, Wang A, Tang C, Chan O et al. Type 1 corticotrophin releasing factor receptors (CRFR1) in the ventromedial hypothalamus (VMH) promote hypoglycemia-induced hormonal counterregulation. Am J Physiol 2007 293 : E705 712.
109. Gabriely I, Hawkins M, Vilcu C, Rossetti L, Shamoon H. Fructose amplifies counterregulatory responses to hypoglycemia in humans. Diabetes 2002 51 : 893 900.
110. Gabriely I, Shamoon H. Fructose normalizes specific counterregulatory responses to hypoglycemia in patients with Type 1 diabetes. Diabetes 2005 54 : 609 616.